21 results
8-K
EX-99.1
LIANY
LianBio
1 May 23
Regulation FD Disclosure
7:28am
: Significant Unmet Needs in China Treatment goals: relieving clinical symptoms, improving cardiac function, delaying disease progression
DEFR14A
LIANY
LianBio
28 Apr 22
Revised proxy
5:10pm
for appropriate rewards and incentives for our management and employees;
reviewing and recommending to our Board for approval corporate goals and objectives … on individual performance goals, as well as corporate goals related to our product development and advancement of clinical studies established by our CEO
DEF 14A
LIANY
LianBio
27 Apr 22
Definitive proxy
8:17am
and recommending to our Board for approval corporate goals and objectives relevant to compensation of our chief executive officer and our other executive officers … bonus for each of our fiscal years, with such bonus awarded based on individual performance goals, as well as corporate goals related to our product
10-K
9q9u34
31 Mar 22
Annual report
8:55am
10-Q
n7mwfrb9bt1g58jip
9 Dec 21
Quarterly report
5:24pm
424B4
k37yh
2 Nov 21
Prospectus supplement with pricing info
4:02pm
S-1/A
7yl5ts
8 Oct 21
IPO registration (amended)
5:09pm
S-1
EX-10.30
rtug3px423kpine5f 4u
1 Oct 21
IPO registration
4:52pm
S-1
2fox f9cqanrq
1 Oct 21
IPO registration
4:52pm
DRS/A
7czpku 7aprv
21 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
99iwytq
2 Sep 21
Draft registration statement (amended)
12:00am
DRSLTR
1oubx80ficnekcqr82u
1 Sep 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
lklys
19 Aug 21
Letter from SEC
12:00am
DRS/A
clq9yrjr
9 Aug 21
Draft registration statement (amended)
12:00am